Love ni love stories movie
More

    Sun Pharma to acquire US-based Ocular Technologies

    Must Read

    Vadodara’s students awarded for making Khadi a fashionable & economically sustainable trend of today

    Students of design from Parul University’s was awarded for making Khadi a fashionable and economically sustainable trend of...

    19 January- Know your today’s horoscope

    Aries: Get involved in activities that are exciting and keep you relaxed. People who had invested their...

    1st edition of Vadodara Invitational Supercross racing and freestyle motocross under floodlights on Sunday

    28 riders from various countries including India will set the track on fire

    Indian drug major Sun Pharmaceutical Industries Ltd has entered into definitive agreements by its wholly owned subsidiary to acquire Ocular Technologies, Sarl (OTS), the company said.

    In a statement issued late Wednesday, Sun Pharma said OTS was a portfolio company of Auven Therapeutics (Auven), an international private equity firm focused on accelerated development of breakthrough therapeutic drugs.

    Sun Pharma will pay Auven $40 million upfront, plus contingent development milestones and sales milestones as well as tiered royalty on sales of Seciera as consideration for this acquisition.

    OTS owns exclusive, worldwide rights to Seciera (cyclosporine A, 0.09 per cent ophthalmic solution).

    Seciera is currently in a Phase-3 confirmatory clinical trial for the treatment of Dry Eye Disease, an inflammatory ocular disease affecting approximately 16 million people in the US alone.

    Seciera is a patented, novel, proprietary formulation of cyclosporine A 0.09 per cent.

    “This potential acquisition signifies continued momentum in enhancing our global branded specialty portfolio,” Dilip Shanghvi, Managing Director, Sun Pharma, was quoted as saying in the statement.

    “Coupled with our existing pipeline consisting of BromSite, DexaSite and Xelpros, this initiative will enable Sun Pharma to significantly expand its ophthalmic presence and reach millions of patients globally,” he said.

    The transaction is subject to approval of the US Federal Trade Commission as required under the Hart-Scott-Rodino Act and other closing conditions and is expected to be completed by end of 2016.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    - Advertisement -

    Latest News

    Vadodara’s students awarded for making Khadi a fashionable & economically sustainable trend of today

    Students of design from Parul University’s was awarded for making Khadi a fashionable and economically sustainable trend of...

    19 January- Know your today’s horoscope

    Aries: Get involved in activities that are exciting and keep you relaxed. People who had invested their money in the past are...

    1st edition of Vadodara Invitational Supercross racing and freestyle motocross under floodlights on Sunday

    28 riders from various countries including India will set the track on fire For the First time in...

    Nisarg Chadha student of Navrachana school topped Gujarat with 100 percentile marks in JEE Mains

    Nisarg Chadha a student of Navrachana school in Vadodara topped Gujarat with 100 percentile marks in JEE Mains. He has been...

    To lit the hearts, Ravneet and Mumbiker Nikhil coming up with their romantic song ‘Lifeline’

    Countdown for Ravneet's next romantic song has commenced only after the release of his poster of his upcoming track 'Lifeline' featuring by...
    - Advertisement -

    More Articles Like This

    - Advertisement -